Long-term effects of platin and anthracycline derivatives and possible prevention strategies.
Hartmann
Jörg Thomas
JT
Department of Hematology/Oncology/Immunology, Eberhard Karls University, Tübingen, Germany. joerg.hartmann@med.uni-tuebingen.de
D018943:Anthracyclines / Q000009:adverse effects*; D002945:Cisplatin / Q000009:adverse effects*; D004427:Ear Diseases / Q000139:chemically induced / Q000517:prevention & control*; D007758:Ear, Inner / Q000187:drug effects; D006321:Heart / Q000187:drug effects; D006331:Heart Diseases / Q000139:chemically induced / Q000517:prevention & control*; D006801:Humans; D007668:Kidney / Q000187:drug effects; D007674:Kidney Diseases / Q000139:chemically induced / Q000517:prevention & control*; D009369:Neoplasms / Q000188:drug therapy*; D017933:Peripheral Nervous System / Q000187:drug effects; D010523:Peripheral Nervous System Diseases / Q000139:chemically induced / Q000517:prevention & control*
D018943:Anthracyclines; D002945:Cisplatin